Literature DB >> 20675031

Immediate-type drug hypersensitivity and associated factors in a general population.

E Kurt1, A U Demir, O Cadirci, H Yildirim, T Pinar Eser.   

Abstract

BACKGROUND: Our aim was to assess the prevalence and associated risk factors of common hypersensitivity reactions to drugs in the adult population, for which limited data are available.
METHODS: The data consisted of 1052 questionnaires obtained from adults. The questionnaires consisted of questions on immediate-type hypersensitivity reactions induced by drugs (itching, skin rash/hives, angio-oedema, shortness of breath, hypotension, and loss of consciousness). The questionnaire added knowledge on physician's diagnosis of asthma, allergic rhinitis, eczema, and other chronic systemic diseases.
RESULTS: The prevalence of self-reported drug hypersensitivity reactions was 11.8% for all reactions. Hypersensitivity reactions to analgesics were the most common (37.2%) followed by antibiotics (24.2%). Multivariate analysis showed that female gender (Odds Ratio (OR) 95% Confidence Interval (CI) (2.00 (1.25-3.21)), physician-diagnosed allergic rhinitis (3.03 (1.64-5.59)), and eczema (3.22 (1.87-5.53)) were associated with any type of drug hypersensitivity reactions. Itching was associated with allergic rhinitis (4.50 (2.06-9.81)) and eczema diagnosis (4.24 (2.14-8.64)). Skin rash/hives were associated with female gender (2.67 (1.24-5.74)), allergic rhinitis (4.57 (1.99-10.05)), and eczema (5.36 (2.65-10.84)). Angio-oedema was higher in females (5.74 (1.69-18.5)). In addition, eczema (2.87 (1.12-7.32)) and systemic hypertension (2.60(1.03-6.10)) were associated with angio-oedema. Shortness of breath was only associated with ever asthma diagnosis (6.59 (2.09-20.83)). Factors associated with loss of consciousness were female gender (5.56 (1.27-24.30)), allergic rhinitis diagnosis (4.76 (1.73-13.14)), and systemic hypertension (2.74 (1.02-7.41)).
CONCLUSION: The study showed that females and subjects with allergic diseases and hypertension were more susceptible to drug hypersensitivity reactions.
Copyright © 2009 SEICAP. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20675031     DOI: 10.1016/j.aller.2010.02.009

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  6 in total

1.  N-acetyltransferase 2 enzyme genotype-phenotype discordances in both HIV-negative and HIV-positive Nigerians.

Authors:  Olayinka A Kotila; Olufunmilayo I Fawole; Olufunmilayo I Olopade; Adejumoke I Ayede; Adeyinka G Falusi; Chinedum P Babalola
Journal:  Pharmacogenet Genomics       Date:  2019-07       Impact factor: 2.089

2.  Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.

Authors:  Tugba Arikoglu; Gulen Aslan; Sehra Birgul Batmaz; Gulcin Eskandari; Ilter Helvaci; Semanur Kuyucu
Journal:  Int J Clin Pharm       Date:  2015-03-31

3.  Multiple hypersensitivities including recurrent airway obstruction, insect bite hypersensitivity, and urticaria in 2 warmblood horse populations.

Authors:  D Kehrli; V Jandova; K Fey; P Jahn; V Gerber
Journal:  J Vet Intern Med       Date:  2014-09-30       Impact factor: 3.333

4.  Self-reported sulphonamide hypersensitivity reactions in adults living in Ibadan, Nigeria: A cross-sectional, community-based study.

Authors:  Akpan Richard Mary; Kotila Adejoke Olayinka; Akpa Matthew Onoja; Fawole Olufunmilayo; Falusi Gladys Adeyinka; Babalola Peace Chinedum
Journal:  Niger Med J       Date:  2015 Nov-Dec

5.  Insect Bite Hypersensitivity in Horses is Associated with Airway Hyperreactivity.

Authors:  S Lanz; A Brunner; C Graubner; E Marti; V Gerber
Journal:  J Vet Intern Med       Date:  2017-09-18       Impact factor: 3.333

6.  Comorbidities and Cofactors of Anaphylaxis in Patients with Moderate to Severe Anaphylaxis. Analysis of Data from the Anaphylaxis Registry for West Pomerania Province, Poland.

Authors:  Iwona Poziomkowska-Gęsicka; Magdalena Kostrzewska; Michał Kurek
Journal:  Int J Environ Res Public Health       Date:  2021-01-05       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.